Buy 3 and get 1 for FREE
Dragon Pharma, Europe
Aromasin
Oral · 25 mg · 100 tabs
$106.00
Buy 3 and get 1 for FREE
Buy 5+ for $98.58 and save $37.10
Compound ID
Exemestane
Dosage
12.5–25 mg/day
Concentration
25 mg/tablet
Form
100 Tablets × 25 mg
Half-life
Approximately 9 hours
Properties
Shipping
Not available in this combination
Product overview
Dragon Pharma Aromasin 25 — Steroidal Aromatase Inhibitor for Complete Estrogen Control
Dragon Pharma Aromasin 25 delivers 25mg of pharmaceutical-grade exemestane per tablet, offering a suicidal approach to estrogen management for athletes running aromatizing compounds. Unlike reversible anti-estrogens, this steroidal AI permanently deactivates the aromatase enzyme, eliminating the risk of estrogen rebound upon discontinuation. Each batch is analytically verified for potency, providing the precision required for effective on-cycle support and post-cycle transition protocols.
What is Dragon Pharma Aromasin 25?
This oral ancillary contains exemestane, a steroidal aromatase inhibitor structurally derived from androstenedione. It belongs to the suicidal or irreversible class of estrogen blockers, meaning it forms a permanent bond with the target enzyme.
Originally developed for therapeutic hormone management, this compound has become a staple in performance enhancement for athletes using testosterone esters, boldenone, or methandienone. The 25mg tablet strength allows for flexible micro-dosing, accommodating everything from conservative testosterone support to aggressive multi-compound stacks.
Key Benefits / Effects
- Irreversible Enzyme Binding: As a suicidal AI, it permanently destroys aromatase molecules. The body must synthesize entirely new enzymes, preventing estrogen rebound common with non-steroidal alternatives.
- Gynecomastia Prevention: By slashing circulating estradiol by up to 85%, it eliminates the hormonal trigger for glandular tissue formation behind the nipples.
- Subcutaneous Water Reduction: Lower estrogen minimizes bloating and fluid retention, producing a harder, more defined musculature with visible vascularity.
- PCT Suitability: Because it does not cause rebound estrogen spikes upon cessation, this compound can be integrated into early post-cycle therapy alongside SERMs.
- Favorable Lipid Profile: Many users report a milder impact on HDL cholesterol compared to non-steroidal aromatase inhibitors when dosed responsibly.
- Flexible Micro-Dosing: The 25mg tablet splits cleanly into precise 12.5mg or 6.25mg increments, enabling accurate titration across mild to extreme aromatizing protocols.
How Dragon Pharma Aromasin 25 Works
Exemestane functions as a mechanism-based inhibitor that covalently binds to the aromatase enzyme's active site. This irreversible inactivation halts the conversion of androgens into estrogen at the source.
Because the enzyme is permanently destroyed rather than temporarily blocked, circulating estradiol drops sharply and remains suppressed until the body generates new aromatase. This pharmacological distinction eliminates the estrogen surge that can occur when discontinuing reversible inhibitors like anastrozole.
The steroidal backbone also imparts mild androgenic properties at the receptor level, which may contribute to the compound's unique side effect profile compared to non-steroidal estrogen management agents.
Usage Information
This anti-estrogen is supplied in 25mg oral tablets. Most athletes begin with 12.5mg every other day during moderate cycles involving 300–500mg weekly of testosterone.
More aggressive aromatizing stacks may require 12.5mg daily. Only the most estrogenic multi-compound protocols warrant the full 25mg daily dose. Administration typically begins 1–2 weeks after cycle initiation, once exogenous hormone levels start converting to estradiol.
Due to its irreversible mechanism and lack of rebound, some protocols incorporate this compound into the first 1–2 weeks of post-cycle therapy at a low dose. Always start conservatively, as over-suppression crashes estrogen and causes joint pain, fatigue, and diminished libido.
Quality & Manufacturing
Independent laboratory analysis confirms each tablet contains 24.21mg of active exemestane, demonstrating exceptional batch consistency. This precision matters because estrogen management depends entirely on micro-dosing accuracy.
Manufacturing under pharmaceutical-grade conditions ensures tablet hardness and uniformity suitable for clean splitting. For a suicidal AI where dose-response is steep, verified potency protects against both insufficient suppression and excessive estrogen depletion.
Possible Side Effects / Safety Information
- Estrogen Crash: Over-suppression causes aching joints, emotional blunting, low libido, and chronic fatigue. Reduce dosage or pause administration if these symptoms emerge.
- Cholesterol Shifts: While generally milder than non-steroidal alternatives, this compound can still lower HDL. Maintain omega-3 intake, dietary fiber, and regular cardiovascular exercise.
- Mild Androgenic Activity: The steroidal structure carries theoretical potential for androgenic expression at very high doses, though this is uncommon at standard bodybuilding protocols.
- Bone Density: Chronic, long-term estrogen suppression may impact mineral density over time. This is primarily a concern in extended therapeutic contexts rather than typical cycle durations.
Why Choose Dragon Pharma Aromasin 25?
The irreversible mechanism of this steroidal AI offers a distinct advantage over reversible estrogen blockers. Athletes transitioning into post-cycle therapy avoid the rebound spikes that can complicate hormonal recovery.
Verified 25mg potency and tablet uniformity enable precise dose splitting for accurate micro-titration. For those seeking dependable estrogen management without the withdrawal complications of traditional aromatase inhibitors, this compound provides a pharmacologically superior solution.
Lab Report
Lab Report: 24.2 mg/tab
27 Aug 2025
25 mg/tab of label claim
| Analysis Date | 2025-08-27 |
| Lot / Batch ID | #EMASRHD |
| Measured Potency | 24.2 mg/tab |
| Quality Assessment | Potency verified, purity passed, heavy metals passed. |
| Current Production Batch | Latest Batch |
Verify this result with your scratch-off code at the DPStore register.
Product FAQ
Questions, answered
Exemestane is a steroidal suicidal aromatase inhibitor that permanently destroys the aromatase enzyme. Non-steroidal AIs like anastrozole only block the enzyme temporarily, allowing estrogen rebound when discontinued.
Arimidex is a reversible non-steroidal inhibitor. This product binds irreversibly, eliminating rebound risk. Many users also report a gentler impact on lipid profiles compared to non-steroidal alternatives.
Begin 1–2 weeks after initiating your cycle, once aromatizing compounds start elevating estradiol. Starting too early may crash estrogen before it rises; starting too late allows gynecomastia to develop.
Most users start with 12.5mg every other day during moderate testosterone protocols. Increase to 12.5mg daily or 25mg daily only if symptoms of high estrogen persist.
It can halt progression and may reduce early-stage glandular tissue by eliminating the estrogenic stimulus. Established, long-standing gynecomastia typically requires surgical intervention.
Yes. Because it causes no estrogen rebound, it can be used during the first 1–2 weeks of PCT alongside SERMs like Nolvadex and Clomid. This prevents estrogen spikes while natural testosterone recovers.
Dry, painful joints, depressed mood, loss of libido, and fatigue indicate crashed estrogen. Reduce your dose immediately and allow levels to recover before resuming.
Use a pill cutter to divide tablets into 12.5mg halves or 6.25mg quarters. The pharmaceutical-grade press ensures clean, even breaks for accurate micro-dosing.
It can lower HDL and raise LDL, though generally less severely than non-steroidal aromatase inhibitors. Regular cardiovascular exercise and a diet rich in healthy fats help mitigate this effect.
Female athletes rarely require estrogen suppression. Crushing estradiol in women causes severe hormonal disruption, bone density loss, and is generally contraindicated unless under direct medical supervision.
The suicidal mechanism permanently destroys aromatase enzymes. Reversible inhibitors detach from the enzyme upon clearance, allowing rapid estrogen resynthesis. With this steroidal AI, the body must manufacture entirely new enzymes, creating a gradual, controlled recovery.
Exemestane is fat-soluble. Taking it with a meal containing dietary fats improves absorption and maintains more stable blood levels compared to fasted administration.
Complete the cycle
